カテゴリ： MarketLine, アメリカ, 企業調査

Achillion Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4614
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Achillion Pharmaceuticals (Achillion or ‘the company’) is an American biopharmaceutical company that develops, discovers, and markets drugs for the treating infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. The company is developing ACH-5228, a factor D inhibitor that is in Phase I clinical trial; ACH-5548, a factor D inhibitor; and other factor D inhibitors. It has license agreements with GCA Therapeutics, Ltd and Ora, Inc., as well as a collaboration arrangement with Janssen Pharmaceuticals Inc. The company operates in the US. The company is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Achillion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Achillion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Achillion Pharmaceuticals, Inc.: Company Overview
Achillion Pharmaceuticals, Inc.: Overview and Key Facts
Achillion Pharmaceuticals, Inc.: Overview
Achillion Pharmaceuticals, Inc.: Key Facts
Achillion Pharmaceuticals, Inc.: Key Employees
Achillion Pharmaceuticals, Inc.: Key Employee Biographies
Achillion Pharmaceuticals, Inc.: Major Products and Services
Achillion Pharmaceuticals, Inc.: Company History
Achillion Pharmaceuticals, Inc.: Management Statement
Achillion Pharmaceuticals, Inc.: Key Competitors
Achillion Pharmaceuticals, Inc.: Company Analysis
Achillion Pharmaceuticals, Inc.: Business Description
Achillion Pharmaceuticals, Inc.: SWOT Analysis
Achillion Pharmaceuticals, Inc.: SWOT Overview
Achillion Pharmaceuticals, Inc.: Strengths
Achillion Pharmaceuticals, Inc.: Weaknesses
Achillion Pharmaceuticals, Inc.: Opportunities
Achillion Pharmaceuticals, Inc.: Threats
Achillion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Achillion Pharmaceuticals, Inc.: Financial Deals Overview
Achillion Pharmaceuticals, Inc.: Targets and Partners
Achillion Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Achillion Pharmaceuticals, Inc.: Advisors
Achillion Pharmaceuticals, Inc.: Top Legal Advisors
Achillion Pharmaceuticals, Inc.: Top Financial Advisors
Achillion Pharmaceuticals, Inc.: Capital Raising
Achillion Pharmaceuticals, Inc.: Private Equity and Ownership
Achillion Pharmaceuticals, Inc.: Recent Developments
Achillion Pharmaceuticals, Inc.: News and Events Summary
Achillion Pharmaceuticals, Inc.: Business Expansion
Achillion Pharmaceuticals, Inc.: Corporate Governance
Achillion Pharmaceuticals, Inc.: Financial Performance
Achillion Pharmaceuticals, Inc.: Market Developments
Achillion Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Achillion Pharmaceuticals, Inc.: Key Facts
Table 2: Achillion Pharmaceuticals, Inc.: Key Employees
Table 3: Achillion Pharmaceuticals, Inc.: Company History
Table 4: Achillion Pharmaceuticals, Inc.: Key Competitors
Table 5: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Achillion Pharmaceuticals, Inc.: Targets and Partners
Table 8: Achillion Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 9: Achillion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Achillion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 14: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 15: Achillion Pharmaceuticals, Inc.: News and Events Summary
Table 16: Achillion Pharmaceuticals, Inc.: Business Expansion
Table 17: Achillion Pharmaceuticals, Inc.: Corporate Governance
Table 18: Achillion Pharmaceuticals, Inc.: Financial Performance
Table 19: Achillion Pharmaceuticals, Inc.: Market Developments
Table 20: Achillion Pharmaceuticals, Inc.: Research & Development

★海外企業調査レポート[Achillion Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Verastem Inc (VSTM)：企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a biopharmaceutical company which focus on the discovery, development and commercialization of novel small molecule drugs to treat cancer. The company’s marketed product COPIKTRA, an oral inhibitor of phosphoinositide 3-kinase (PI3K) is used to hematologic malignan …
  • Noranda Income Fund (NIF.UN)：企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ContraFect Corp (CFRX)：企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) operates as a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious …
  • Ambry Genetics Corp-製薬・医療分野：企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • Progenity Inc：医療機器：M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Haci Omer Sabanci Holding A.S. (SAHOL)-エネルギー分野：企業M&A・提携分析
    Summary Haci Omer Sabanci Holding A.S. (Sabanci) is an industrial and financial conglomerate. The company carries out banking, insurance, energy, retail, cement, insurance, automotive, tire and tire reinforcement materials businesses. The company has partnerships with various multinational business …
  • Iridex Corp (IRIX)：企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • GS Retail Co., Ltd. (007070)：企業の財務・戦略的SWOT分析
    GS Retail Co., Ltd. (007070) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PharmaZell GmbH：企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Checkpoint Systems, Inc.：企業の戦略・SWOT・財務分析
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • TransMontaigne Product Services LLC：企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Blue Nile, Inc.：企業の戦略・SWOT・財務情報
    Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report Summary Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hotel Dubrovnik d.d.：企業の戦略・SWOT・財務分析
    Hotel Dubrovnik d.d. - Strategy, SWOT and Corporate Finance Report Summary Hotel Dubrovnik d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mexco Energy Corp：企業の財務・戦略的SWOT分析
    Summary Mexco Energy Corp (Mexco Energy) is an oil and gas company that offers exploration, acquisition, production, and development of crude oil, natural gas, condensate liquids, and natural gas liquids. The company acquires producing and non-producing oil and gas leases from landowners and leaseho …
  • Quadra – Power Generation：企業の発電所・SWOT分析2018
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Gannett Co., Inc.：戦略・SWOT・企業財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mereo Biopharma Group Plc (MPH)：企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Global Payments Inc. (GPN)：企業の財務・戦略的SWOT分析
    Global Payments Inc. (GPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • EDF Energy Holdings Ltd：発電所・企業SWOT分析
    EDF Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Ontario Power Generation Inc.：企業の戦略・SWOT・財務情報
    Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report Summary Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆